메뉴 건너뛰기




Volumn 28, Issue 12, 2010, Pages 2458-2464

A novel canine favored CpG oligodeoxynucleotide capable of enhancing the efficacy of an inactivated aluminum-adjuvanted rabies vaccine of dog use

Author keywords

CpG ODN; Dog; Rabies vaccine

Indexed keywords

ALUMINUM; CPG OLIGODEOXYNUCLEOTIDE; INACTIVATED VACCINE; KENNEL COUGH VACCINE; RABIES VACCINE;

EID: 77249134997     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.12.077     Document Type: Article
Times cited : (14)

References (30)
  • 1
    • 33746531012 scopus 로고    scopus 로고
    • First report
    • WHO Expert Consultation on Rabies, Geneva: World Health Organization;
    • WHO Expert Consultation on Rabies. First report. Geneva: World Health Organization; 2004. (WHO Technical Report Series; 931).
    • (2004) WHO Technical Report Series , vol.931
  • 3
    • 0024115067 scopus 로고
    • Organization of mass vaccination for dog rabies in Brazil
    • Bellotto A.J. Organization of mass vaccination for dog rabies in Brazil. Rev Infect Dis 10 Suppl. 4 (1988) S693-S696
    • (1988) Rev Infect Dis , vol.10 , Issue.SUPPL. 4
    • Bellotto, A.J.1
  • 4
    • 0027521358 scopus 로고
    • Immune response to rabies vaccine in Alaskan dogs: failure to achieve a consistently protective antibody response
    • Sage G., Khawplod P., Wilde H., Lobaugh C., Hemachudha T., Tepsumethanon W., et al. Immune response to rabies vaccine in Alaskan dogs: failure to achieve a consistently protective antibody response. Trans R Soc Trop Med Hyg 87 5 (1993) 593-595
    • (1993) Trans R Soc Trop Med Hyg , vol.87 , Issue.5 , pp. 593-595
    • Sage, G.1    Khawplod, P.2    Wilde, H.3    Lobaugh, C.4    Hemachudha, T.5    Tepsumethanon, W.6
  • 5
    • 57649130993 scopus 로고    scopus 로고
    • Comparison of antibody responses after vaccination with two inactivated rabies vaccines
    • Minke J.M., Bouvet J., Cliquet F., Wasniewski M., Guiot A.L., Lemaitre L., et al. Comparison of antibody responses after vaccination with two inactivated rabies vaccines. Vet Microbiol 133 3 (2009) 283-286
    • (2009) Vet Microbiol , vol.133 , Issue.3 , pp. 283-286
    • Minke, J.M.1    Bouvet, J.2    Cliquet, F.3    Wasniewski, M.4    Guiot, A.L.5    Lemaitre, L.6
  • 6
    • 51349150734 scopus 로고    scopus 로고
    • Antibody response to an anti-rabies vaccine in a dog population under field conditions in Bolivia
    • Suzuki K., González E.T., Ascarrunz G., Loza A., Pérez M., Ruiz G., et al. Antibody response to an anti-rabies vaccine in a dog population under field conditions in Bolivia. Zoonoses Public Health 55 8-10 (2008) 414-420
    • (2008) Zoonoses Public Health , vol.55 , Issue.8-10 , pp. 414-420
    • Suzuki, K.1    González, E.T.2    Ascarrunz, G.3    Loza, A.4    Pérez, M.5    Ruiz, G.6
  • 8
    • 0030892283 scopus 로고    scopus 로고
    • T cells and viral hepatitis
    • Chisari F.V., and Cytotoxic. T cells and viral hepatitis. J Clin Invest 99 7 (1997) 1472-1477
    • (1997) J Clin Invest , vol.99 , Issue.7 , pp. 1472-1477
    • Chisari, F.V.1    Cytotoxic2
  • 9
    • 0034678409 scopus 로고    scopus 로고
    • T cells in hepatitis B: viral control versus liver cell injury
    • Rehermann B., and Intrahepatic. T cells in hepatitis B: viral control versus liver cell injury. J Exp Med 191 8 (2000) 1263-1268
    • (2000) J Exp Med , vol.191 , Issue.8 , pp. 1263-1268
    • Rehermann, B.1    Intrahepatic2
  • 10
    • 40649096399 scopus 로고    scopus 로고
    • Protection of mice from rabies by intranasal immunization with inactivated rabies virus
    • Yoneda A., Tuchiya K., Takashima Y., Arakawa T., Tsuji N., Hayashi Y., et al. Protection of mice from rabies by intranasal immunization with inactivated rabies virus. Exp Anim 57 1 (2008) 1-9
    • (2008) Exp Anim , vol.57 , Issue.1 , pp. 1-9
    • Yoneda, A.1    Tuchiya, K.2    Takashima, Y.3    Arakawa, T.4    Tsuji, N.5    Hayashi, Y.6
  • 12
    • 0032526607 scopus 로고    scopus 로고
    • CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry
    • Yi A.K., Chang M., Peckham D.W., Krieg A.M., and Ashman R.F. CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry. J Immunol 160 12 (1998) 5898-5906
    • (1998) J Immunol , vol.160 , Issue.12 , pp. 5898-5906
    • Yi, A.K.1    Chang, M.2    Peckham, D.W.3    Krieg, A.M.4    Ashman, R.F.5
  • 13
    • 0033529891 scopus 로고    scopus 로고
    • CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells
    • Hartmann G., Weiner G.J., and Krieg A.M. CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc Natl Acad Sci USA 96 16 (1999) 9305-9310
    • (1999) Proc Natl Acad Sci USA , vol.96 , Issue.16 , pp. 9305-9310
    • Hartmann, G.1    Weiner, G.J.2    Krieg, A.M.3
  • 14
    • 0030613651 scopus 로고    scopus 로고
    • CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity
    • Chu R.S., Targoni O.S., Krieg A.M., Lehmann P.V., and Harding C.V. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med 186 10 (1997) 1623-1631
    • (1997) J Exp Med , vol.186 , Issue.10 , pp. 1623-1631
    • Chu, R.S.1    Targoni, O.S.2    Krieg, A.M.3    Lehmann, P.V.4    Harding, C.V.5
  • 15
    • 0032889105 scopus 로고    scopus 로고
    • CpG motifs as immune adjuvants
    • Klinman D.M., Barnhart K.M., and Conover J. CpG motifs as immune adjuvants. Vaccine 17 1 (1999) 19-25
    • (1999) Vaccine , vol.17 , Issue.1 , pp. 19-25
    • Klinman, D.M.1    Barnhart, K.M.2    Conover, J.3
  • 17
    • 0034142182 scopus 로고    scopus 로고
    • Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo
    • Hartmann G., Weeratna R.D., Ballas Z.K., Payette P., Blackwell S., Suparto I., et al. Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. J Immunol 164 3 (2000) 1617-1624
    • (2000) J Immunol , vol.164 , Issue.3 , pp. 1617-1624
    • Hartmann, G.1    Weeratna, R.D.2    Ballas, Z.K.3    Payette, P.4    Blackwell, S.5    Suparto, I.6
  • 18
    • 11344257404 scopus 로고    scopus 로고
    • CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study
    • Cooper C.L., Davis H.L., Morris M.L., Efler S.M., Adhami M.A., Krieg A.M., et al. CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study. J Clin Immunol 24 6 (2004) 693-701
    • (2004) J Clin Immunol , vol.24 , Issue.6 , pp. 693-701
    • Cooper, C.L.1    Davis, H.L.2    Morris, M.L.3    Efler, S.M.4    Adhami, M.A.5    Krieg, A.M.6
  • 19
    • 0037178315 scopus 로고    scopus 로고
    • CpG-containing oligodeoxynucleotides augment and switch the immune responses of cattle to bovine herpesvirus-1 glycoprotein D
    • Rankin R., Pontarollo R., Gomis S., Karvonen B., Willson P., Loehr B.I., et al. CpG-containing oligodeoxynucleotides augment and switch the immune responses of cattle to bovine herpesvirus-1 glycoprotein D. Vaccine 20 23-24 (2002) 3014-3022
    • (2002) Vaccine , vol.20 , Issue.23-24 , pp. 3014-3022
    • Rankin, R.1    Pontarollo, R.2    Gomis, S.3    Karvonen, B.4    Willson, P.5    Loehr, B.I.6
  • 20
    • 40849095781 scopus 로고    scopus 로고
    • A CpG oligodeoxynucleotide acts as a potent adjuvant for inactivated rabies virus vaccine
    • Wang X., Bao M., Wan M., Wei H., Wang L., Yu H., et al. A CpG oligodeoxynucleotide acts as a potent adjuvant for inactivated rabies virus vaccine. Vaccine 26 15 (2008) 1893-1901
    • (2008) Vaccine , vol.26 , Issue.15 , pp. 1893-1901
    • Wang, X.1    Bao, M.2    Wan, M.3    Wei, H.4    Wang, L.5    Yu, H.6
  • 21
    • 8444219651 scopus 로고    scopus 로고
    • Identification of CpG oligodeoxynucleotide sequences that induce IFN-gamma production in canine peripheral blood mononuclear cells
    • Kurata K., Iwata A., Masuda K., Sakaguchi M., Ohno K., and Tsujimoto H. Identification of CpG oligodeoxynucleotide sequences that induce IFN-gamma production in canine peripheral blood mononuclear cells. Vet Immunol Immunopathol 102 4 (2004) 441-450
    • (2004) Vet Immunol Immunopathol , vol.102 , Issue.4 , pp. 441-450
    • Kurata, K.1    Iwata, A.2    Masuda, K.3    Sakaguchi, M.4    Ohno, K.5    Tsujimoto, H.6
  • 24
    • 0034650517 scopus 로고    scopus 로고
    • Mechanism and function of a newly identified CpG DNA motif in human primary B cells
    • Hartmann G., and Krieg A.M. Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J Immunol 164 2 (2000) 944-953
    • (2000) J Immunol , vol.164 , Issue.2 , pp. 944-953
    • Hartmann, G.1    Krieg, A.M.2
  • 25
    • 0035952189 scopus 로고    scopus 로고
    • Response of porcine peripheral blood mononuclear cells to CpG-containing oligodeognuleotides
    • Kamstrup S., Verthelyi D., and Klinman D.M. Response of porcine peripheral blood mononuclear cells to CpG-containing oligodeognuleotides. Vet Microbiol 78 4 (2001) 353-362
    • (2001) Vet Microbiol , vol.78 , Issue.4 , pp. 353-362
    • Kamstrup, S.1    Verthelyi, D.2    Klinman, D.M.3
  • 26
    • 33645851635 scopus 로고    scopus 로고
    • Immunostimulatory oligodeoxynucleotide isolated from genome wide screening of Mycobacterium bovis chromosomal DNA
    • Lee K.W., Jung J., Lee Y., Kim T.Y., Choi S.Y., Park J., et al. Immunostimulatory oligodeoxynucleotide isolated from genome wide screening of Mycobacterium bovis chromosomal DNA. Mol Immunol 43 13 (2006) 2107-2118
    • (2006) Mol Immunol , vol.43 , Issue.13 , pp. 2107-2118
    • Lee, K.W.1    Jung, J.2    Lee, Y.3    Kim, T.Y.4    Choi, S.Y.5    Park, J.6
  • 27
    • 0037159625 scopus 로고    scopus 로고
    • CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein
    • Ioannou X.P., Gomis S.M., Karvonen B., Hecker R., Babiuk L.A., and van Drunen Littel-van den Hurk S. CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein. Vaccine 21 1-2 (2002) 127-137
    • (2002) Vaccine , vol.21 , Issue.1-2 , pp. 127-137
    • Ioannou, X.P.1    Gomis, S.M.2    Karvonen, B.3    Hecker, R.4    Babiuk, L.A.5    van Drunen Littel-van den Hurk, S.6
  • 28
    • 0036720896 scopus 로고    scopus 로고
    • The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides
    • Ioannou X.P., Griebel P., Hecker R., Babiuk L.A., and van Drunen Littel-van den Hurk S. The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides. J Virol 76 18 (2002) 9002-9010
    • (2002) J Virol , vol.76 , Issue.18 , pp. 9002-9010
    • Ioannou, X.P.1    Griebel, P.2    Hecker, R.3    Babiuk, L.A.4    van Drunen Littel-van den Hurk, S.5
  • 29
    • 33745000276 scopus 로고    scopus 로고
    • The efficacy of CpG oligodinucleotides, in combination with conventional adjuvants, as immunological adjuvants to swine streptococcic septicemia vaccine in piglets in vivo
    • Linghua Z., Xingshan T., and Fengzhen Z. The efficacy of CpG oligodinucleotides, in combination with conventional adjuvants, as immunological adjuvants to swine streptococcic septicemia vaccine in piglets in vivo. Int immunopharmacol 6 8 (2006) 1267-1276
    • (2006) Int immunopharmacol , vol.6 , Issue.8 , pp. 1267-1276
    • Linghua, Z.1    Xingshan, T.2    Fengzhen, Z.3
  • 30
    • 0032768534 scopus 로고    scopus 로고
    • DNA as an adjuvant in vaccination against Leishmania major
    • Stacey K.J., Blackwell J.M., and Immunostimulatory. DNA as an adjuvant in vaccination against Leishmania major. Infect Immun 67 8 (1999) 3719-3726
    • (1999) Infect Immun , vol.67 , Issue.8 , pp. 3719-3726
    • Stacey, K.J.1    Blackwell, J.M.2    Immunostimulatory3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.